Market closedADR

Pharming Group/$PHAR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Pharming Group

Pharming Group is a biopharmaceutical company. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome. In addition, the firm's development pipeline includes KL1333, a potential first-in-disease asset for mitochondrial DNA-driven primary mitochondrial diseases. The company's reportable segments are RUCONEST, which derives maximum revenue, Joenja, U.S., and Europe and the Rest of the World (RoW). Geographically, it derives maximum revenue from the United States.

Ticker

$PHAR
Trading on

Industry

Biotechnology

Employees

404

Pharming Group Metrics

BasicAdvanced
$553M
-
-$0.02
0.60
-
$553M
0.6
$9.65
$7.50
6.3K
3.773
2.955
47.553
50.806
-0.41%
-1.25%
-5.00%
18.41
2.16
2.98
-2,111.946
21.15%
-0.34%
14.33%
-11.39%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PHAR

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Pharming Group stock?

Pharming Group (PHAR) has a market cap of $553M as of April 23, 2025.

What is the P/E ratio for Pharming Group stock?

The price to earnings (P/E) ratio for Pharming Group (PHAR) stock is 0 as of April 23, 2025.

Does Pharming Group stock pay dividends?

No, Pharming Group (PHAR) stock does not pay dividends to its shareholders as of April 23, 2025.

When is the next Pharming Group dividend payment date?

Pharming Group (PHAR) stock does not pay dividends to its shareholders.

What is the beta indicator for Pharming Group?

Pharming Group (PHAR) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.